Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Glyceryl trinitrate 25mg (releasing 5mg/24h)
Sandoz New Zealand Limited
Glyceryl trinitrate 25 mg (releasing 5mg/24h)
5 mg/24h
Transdermal patch
Active: Glyceryl trinitrate 25mg (releasing 5mg/24h)
Sachet, laminate, 1 x 10, 10 patches
Prescription
Prescription
Dynamit Nobel GmbH
Treatment of angina pectoris as monotherapy or in combination with other anti-anginal drugs such as beta-blockers and/or calcium antagonists.
Package - Contents - Shelf Life: Sachet, laminate, - 10 patches - 36 months from date of manufacture stored at or below 30°C - Sachet, laminate, - 30 patches - 36 months from date of manufacture stored at or below 30°C
1983-03-10
___________________________________________________________________________________________________ Nitroderm TTS 1 NITRODERM TTS _5mg and 10mg transdermal patches _ _glyceryl trinitrate_ _____________________________________________________________________________________ CONSUMER MEDICINE INFORMATION _____________________ WHAT IS IN THIS LEAFLET __________________________________ This leaflet answers some common questions about Nitroderm TTS . It does not contain all the available information . It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date listed on the final page. More recent information on the medicine may be available. YOU SHOULD ENSURE THAT YOU SPEAK TO YOUR PHARMACIST OR DOCTOR TO OBTAIN THE MOST UP-TO-DATE INFORMATION ON THE MEDICINE. YOU CAN ALSO DOWNLOAD THE MOST UP-TO- DATE LEAFLET FROM WWW.MEDSAFE.GOVT.NZ Those updates may contain important information about the medicine and its use of which you should be aware. All medicines have risks and benefits. Your doctor has weighed the risks of you using Nitroderm TTS against the benefits they expect it will provide. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. _______________________ WHAT NITRODERM TTS IS USED FOR ________________________ Nitroderm TTS is an adhesive patch that delivers a medicine called nitroglycerin through the skin and into the bloodstream. Nitroderm TTS is used to prevent or reduce the frequency of angina attacks (chest pain or discomfort). . Nitroderm TTS is also used as a supplementary medicine for the treatment of patients suffering from heart failure who do not respond adequately to conventional therapy. Nitroderm TTS belongs to a group of medicines called nitrates. Nitrates work by widening blood vessels, letting more blood and oxygen reach the heart. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Read the complete document
1 230828-Nitroderm TTS-ds NEW ZEALAND DATA SHEET 1 PRODUCT NAME NITRODERM® TTS 5: 25 mg Transdermal Patch NITRODERM® TTS 10: 50 mg Transdermal Patch 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1,2,3-Propanetriol trinitrate (= nitroglycerin), 25 mg or 50 mg in a transdermal therapeutic system (TTS). Nitroglycerin is an organic nitrate derivative. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Flat multilayer system designed to deliver nitroglycerin continuously through a release membrane following application to the skin. The release membrane limits delivery through hyperpermeable skin. The active substance penetrates the skin and thus becomes directly bioavailable to the systemic circulation at relatively constant concentrations during the recommended application period. The following three systems are available: TABLE 1 NITRODERM PHARMACEUTICAL FORMS NITRODERM TTS 5 NITRODERM TTS 10 Nitroglycerin content 25 mg 50 mg Drug-releasing area 10 cm 2 20 cm 2 Imprint (backing side) CG CG DOD DPD Colour of the release lineroff-white to yellowish The numeric components of the product designations TTS 5 and TTS 10 denote the nominal amount of nitroglycerin in mg delivered by the system per 24 hours. The remainder of the nitroglycerin in each system serves as a reserve and is not delivered in normal use. After 12 hours, for example, each system has delivered 10% of its original content of nitroglycerin. Since nitroglycerin is released from Nitroderm TTS at a constant rate per cm , the dose administered is related to the size of the drug-releasing area. The nominal rate of nitroglycerin release in vivo is approximately 20-25 microgram/cm .h. 2 230828-Nitroderm TTS-ds The following cross-sectional diagram shows the composition of Nitroderm TTS. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS TREATMENT OF ANGINA PECTORIS As monotherapy or in combination with other anti anginal drugs such as beta blockers and/or calcium antagonists. TREATMENT OF CONGESTIVE HEART FAILURE As supplementary medi Read the complete document